Minneapolis — Minneapolis, Minnesota

Minneapolis is a clinical research site located in Minneapolis, Minnesota, United States 55407.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Minneapolis has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Colorectal Cancer Metastatic, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction.

Sponsors: Boston Scientific Corporation, Tectonic Therapeutic, Promontory Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minneapolis?

Minneapolis has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minneapolis conducted?

Minneapolis has 5 clinical trials on record, with 2 currently active. Their work covers Colorectal Cancer Metastatic, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction.

Is Minneapolis accredited by Crixeo Health?

Yes — Minneapolis holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Minneapolis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.